Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibody Totality of evidence from the ...

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian ...

Every year, bacteria kill more than a million people worldwide through infections that no longer respond to antibiotics. In ...

Phase 3 clinical trial will evaluate aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab versus standard-of-care docetaxel chemotherapy in patie ...

Q3 2026 FDA oncology verdicts loom for ADCs and targeted drugs in breast, melanoma, gastric, blood, and lung cancers. The third quarter of 2026 brings a fresh slate of high-stakes FDA decisions across ...

Mechelen, Belgium; June 29, 2026, 22.01 CET; regulated information - Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Madison Avenue Partners. Pursuant ...

Nuvation Bio , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in ...

LONDON — Cellular therapy continues to advance treatment options for severe, refractory autoimmune diseases, according to newly released data presented at the European Alliance of Associations for ...

ICSE board has released the official syllabus for classes 9 to 12 to help students prepare for the board exams. Students can ...

More than 670 people have been infected in Utah’s measles outbreak and the cases that should alarm us most are the ones no ...

Immunis, a clinical-stage biotech company developing a first-in-class multi-active biologic, announced the launch of its new ...